PTH and Hypocalcemia: On the contrary, calcimimetic agents, such as cinacalcet and etelcalcetide, which increase the sensitivity of the calcium-sensing receptor to extracellular calcium and decrease PTH secretion [14], may cause hypocalcemia [15, 16], leading to an increased risk of arrhythmia and heart failure [17].